We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Lithium-discontinuation-induced treatment refractoriness revisited

    Background

    Lithium is effective in the long-term treatment of bipolar disorder. Concerns have been raised about non-responsiveness after...

    Ralph Kupka, Eline Regeer, ... Michael Bauer in International Journal of Bipolar Disorders
    Article Open access 15 May 2024
  2. Rebound activation of 5-HT neurons following SSRI discontinuation

    Cessation of therapy with a selective serotonin (5-HT) reuptake inhibitor (SSRI) is often associated with an early onset and disabling...

    Helen M. Collins, L. Sophie Gullino, ... Trevor Sharp in Neuropsychopharmacology
    Article Open access 12 April 2024
  3. Disentangling pharmacological and expectation effects in antidepressant discontinuation among patients with fully remitted major depressive disorder: study protocol of a randomized, open-hidden discontinuation trial

    Background

    Antidepressants are established as an evidence-based, guideline-recommended treatment for Major Depressive Disorder. Prescriptions have...

    Carina Meißner, Claire Warren, ... Yvonne Nestoriuc in BMC Psychiatry
    Article Open access 21 June 2023
  4. Denosumab Discontinuation

    Purpose of Review

    To review the pathophysiology, the clinical consequences as well as way of mitigating the effects of denosumab discontinuation.

    ...
    Anne Sophie Sølling, Elena Tsourdi, ... Bente L Langdahl in Current Osteoporosis Reports
    Article 24 December 2022
  5. Discontinuation of psychotropic medication: a synthesis of evidence across medication classes

    Pharmacotherapy is an effective treatment modality across psychiatric disorders. Nevertheless, many patients discontinue their medication at some...

    Christiaan H. Vinkers, Ralph W. Kupka, ... Jurjen J. Luykx in Molecular Psychiatry
    Article Open access 19 March 2024
  6. Discontinuation and nonpublication of clinical trials in orthopaedic oncology

    Background

    Despite the pivotal role of clinical trials in advancing orthopaedic oncology knowledge and treatment strategies, the persistent issues of...

    Gurbinder Singh, Aboubacar Wague, ... Jeffrey Barry in Journal of Orthopaedic Surgery and Research
    Article Open access 05 February 2024
  7. Long–Term Outcome After Discontinuation of CGRP-Targeting Therapy for Migraine

    Purpose of review

    Calcitonin gene-related peptide (CGRP)-targeting agents are potential candidates for disease-modifying migraine drugs. However, most...

    Soohyun Cho, Byung–Kun Kim in Current Pain and Headache Reports
    Article 29 April 2024
  8. Factors associated with discontinuation in fertility treatment: a systematic sco** review

    Purpose

    The discontinuation of fertility treatment could decrease the chances of achieving parenthood for infertile patients and often leads to...

    Quan Shen, Binglu Wang, ... Jun Lei in Journal of Assisted Reproduction and Genetics
    Article 21 November 2023
  9. Discontinuation of antidepressant treatment: a retrospective cohort study on more than 20,000 participants

    Background

    Factors influencing antidepressant treatment discontinuation are poorly understood. In the present study, we aimed to estimate the...

    Luis M. Garcia-Marin, Aoibhe Mulcahy, ... Adrian I. Campos in Annals of General Psychiatry
    Article Open access 24 November 2023
  10. Predictors of contraceptive discontinuation in Rwanda: evidence from demographic and health survey 2019–2020

    Background

    Despite advancements, Rwanda continues to face challenges regarding contraceptive discontinuation. The 2019–2020 Rwanda Demographic and...

    Harerimana Jean de Dieu, Mugabo Lambert in Contraception and Reproductive Medicine
    Article Open access 25 April 2024
  11. Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans

    US female veterans have higher rates of mental health (MH) disorders compared to US civilian females and, consequently, are at risk for poor MH...

    Megan Howard, Tracey Ledoux, ... Deleene S. Menefee in Archives of Women's Mental Health
    Article 23 September 2023
  12. Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry

    Background

    Remdesivir is an antiviral approved by the US Food and Drug Administration (FDA) for treatment of coronavirus disease 2019 (COVID-19), and...

    Jonathan Schimmel, Lindsey Claire Epperson, ... Keith Burkhart in Drugs
    Article 10 January 2024
  13. Association between prognostic nutritional index and peritoneal dialysis discontinuation: a retrospective cohort study

    Background

    Malnutrition is associated with discontinuing peritoneal dialysis (PD). The prognostic nutritional index (PNI), composed of serum albumin...

    Yoshikazu Miyasato, Jun Morinaga, ... Masashi Mukoyama in Renal Replacement Therapy
    Article Open access 07 November 2023
  14. Feasibility and safety of the discontinuation of systemic immunosuppressive treatment after single-unit cord blood transplantation in adults

    We retrospectively evaluated the incidence, factors, and clinical outcomes of the discontinuation of immunosuppressive treatment (IST) after...

    Takaaki Konuma, Maki Monna-Oiwa, ... Satoshi Takahashi in Bone Marrow Transplantation
    Article Open access 13 May 2024
  15. Postoperative use and early discontinuation of intravenous lidocaine in spine patients

    Purpose

    Our institution employs a multimodal approach to manage postoperative pain after spine surgery. It involves continuous intravenous (IV)...

    Paul Brian O. Soriano, Jason J. Haselhuhn, ... David W. Polly Jr. in Spine Deformity
    Article 23 August 2023
  16. Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims

    Background

    Potential differences in buprenorphine treatment outcomes across various treatment settings are poorly characterized in multi-state...

    Kevin Y. Xu, Alex K. Gertner, ... Richard A. Grucza in Addiction Science & Clinical Practice
    Article Open access 16 March 2024
  17. Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia

    Purpose

    Cancer-associated cachexia, a multifactorial syndrome involving loss of muscle mass and anorexia, is an unremitting problem for cancer...

    Ikuto Tsukiyama, Takashi Iwata, ... Naoharu Mori in Supportive Care in Cancer
    Article Open access 10 October 2023
  18. Peritoneal dialysis discontinuation: to the root of the problem

    As the global burden of chronic kidney disease continues to increase, the use of peritoneal dialysis is often advocated as the preferred initial...

    Paola Piarulli, Valerio Vizzardi, ... Antonio Bellasi in Journal of Nephrology
    Article Open access 25 September 2023
  19. Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation

    Background/Purpose

    Little is known about long-term clinical outcomes or urate-lowering (ULT) therapy use following pegloticase discontinuation. We...

    Emily E. Holladay, Amy S. Mudano, ... Jeffrey R. Curtis in Arthritis Research & Therapy
    Article Open access 12 April 2024
  20. Patient characteristics and reasons for discontinuation in a cardiovascular risk management programme in The Netherlands

    Background

    Since 2010, an increasing number of patients have participated in a nurse-led integrated cardiovascular risk management programme in the...

    Geert H.J.M. Smits, Sander van Doorn, ... Monika Hollander in BMC Primary Care
    Article Open access 11 February 2024
Did you find what you were looking for? Share feedback.